Amdocs (NASDAQ:DOX – Get Free Report) updated its first quarter 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 1.730-1.790 for the period, compared to the consensus earnings per share estimate of 1.780. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion. Amdocs also updated its FY 2026 guidance to 7.270-7.550 EPS.
Amdocs Stock Performance
NASDAQ DOX traded down $1.53 on Tuesday, reaching $83.96. 1,686,286 shares of the company’s stock traded hands, compared to its average volume of 757,578. The stock has a 50 day moving average price of $83.50 and a 200-day moving average price of $87.49. The firm has a market cap of $9.48 billion, a price-to-earnings ratio of 17.03, a P/E/G ratio of 1.40 and a beta of 0.51. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. Amdocs has a fifty-two week low of $78.61 and a fifty-two week high of $95.41.
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings data on Tuesday, November 11th. The technology company reported $1.62 earnings per share for the quarter, missing analysts’ consensus estimates of $1.82 by ($0.20). Amdocs had a net margin of 11.94% and a return on equity of 19.66%. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. Equities research analysts predict that Amdocs will post 6.21 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the business. Millennium Management LLC boosted its holdings in shares of Amdocs by 458.3% during the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock worth $6,135,000 after purchasing an additional 55,038 shares during the last quarter. Merit Financial Group LLC increased its stake in shares of Amdocs by 12.0% in the 3rd quarter. Merit Financial Group LLC now owns 6,533 shares of the technology company’s stock worth $536,000 after acquiring an additional 700 shares during the last quarter. Evergreen Capital Management LLC purchased a new position in shares of Amdocs during the 2nd quarter worth $473,000. Two Sigma Securities LLC acquired a new position in shares of Amdocs during the 2nd quarter valued at about $755,000. Finally, Balyasny Asset Management L.P. grew its holdings in shares of Amdocs by 93.4% in the second quarter. Balyasny Asset Management L.P. now owns 7,644 shares of the technology company’s stock valued at $697,000 after purchasing an additional 3,691 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- Technology Stocks Explained: Here’s What to Know About Tech
- Down 25%, Is Defense Darling Kratos an Attractive Opportunity?
- 5 Top Rated Dividend Stocks to Consider
- Rumble’s $767M Acquisition Marks Bold Pivot Into AI Infrastructure
- 3 Healthcare Dividend Stocks to Buy
- SoftBank Exits NVIDIA—So What? Analysts Still See More Upside
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
